Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Frontier IP Group present in-depth update on portfolio progression, hailing Exscientia IPO success

Frontier IP Group present in-depth update on portfolio progression, hailing Exscientia IPO success

Frontier IP's Neil Crabb joins Proactive London for a thorough analysis of the portfolio's performance in 2021 and what's in store for the new year.

This comes after publishing their trading update this week, with first half numbers expected to beat expectations following the recent flotation of portfolio company Exscientia on Nasdaq.

Frontier IP has now started to sell down some of its stake in Exscientia. It held a 1.7% stake in October. Elsewhere, the rest of its portfolio has continued to make good progress.

The Vaccine Group announced encouraging data on the development of its next-generation COVID-19 vaccine, Camgraphic completed a fundraising and management has been strengthened at Pulsiv.

Celerum, meanwhile, yesterday launched its Truck Logistics System at a time when supply chain challenges are high on the priority list for many businesses.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK